News
In recent years, the U.S. Food and Drug Administration (FDA) has approved a wave of new therapies, including gene therapies, ...
In a heartwrenching series of testimonies, the House Democratic Policy Committee heard about the factors influencing infant ...
Sickle cell crisis is an acute, painful episode and other serious complications that occur in people with sickle cell disease ...
News-Medical.Net on MSN
Clinical trial reveals encouraging results for apitegromab in spinal muscular atrophy
A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in children and adolescents with spinal muscular atrophy, according to a study ...
What to Expect on MSN
What Happens During the Newborn Hearing Screening and Why Your Baby Needs One
The newborn hearing screening is designed to detect hearing abnormalities right after birth, since hearing loss is a common congenital condition among infants. In fact, roughly 2 or 3 out of every ...
A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in children and adolescents ...
With statistics showing that about 17 children are born with hearing loss, Hold My Hand is hosting a webinar titled: "Little Ears, Big Futures: Newborn Hearing Awareness".
The baby was born full-term and healthy, so what happened next didn’t seem to make any sense. He was taken away at the ...
7hon MSN
Coronial inquiry into death of newborn Thea Flaskett concludes with family impact statement read
The mother of the "miracle baby" who died hours after her birth read out a family impact statement to the court, on the final ...
An Australian government research funding programme is helping commercialise a mobile app for screening cerebral palsy in ...
The change was backed by an advisory panel whose members were handpicked by Health and Human Services Secretary Robert F.
Pending the European Commission’s final decision, nipocalimab could be the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results